Company Filing History:
1 out of 29 
1 out of 3,687 
Years Active: 2017
Title: Christopher Steven Rae: Innovator in Cancer Treatment
Introduction
Christopher Steven Rae is a notable inventor based in Richmond, CA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of immunogenic fusion proteins. His work aims to elicit an immune response in subjects, providing new avenues for cancer therapy.
Latest Patents
Christopher Steven Rae holds 1 patent for his invention titled "Immunogenic fusion proteins for the treatment of cancer." This patent encompasses compositions and methods designed to stimulate an immune response in patients. The focus of his research is on immunogenic fusion proteins and the methodologies for utilizing host cells that contain nucleic acid molecules encoding these proteins.
Career Highlights
Throughout his career, Rae has worked with prominent organizations, including Aduro Biotech Inc. and The Johns Hopkins University. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in immunotherapy.
Collaborations
Some of his notable coworkers include Dirk G. Brockstedt and Charles George Drake. Their collective expertise has further advanced the research and development of innovative cancer treatments.
Conclusion
Christopher Steven Rae's contributions to cancer treatment through his patented innovations highlight the importance of research in developing effective therapies. His work continues to inspire advancements in the medical field.